Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HDA7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 135 | 139 | PF00656 | 0.705 |
CLV_C14_Caspase3-7 | 65 | 69 | PF00656 | 0.509 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.747 |
CLV_NRD_NRD_1 | 184 | 186 | PF00675 | 0.723 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.574 |
CLV_NRD_NRD_1 | 223 | 225 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.480 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.623 |
CLV_PCSK_FUR_1 | 182 | 186 | PF00082 | 0.646 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.748 |
CLV_PCSK_KEX2_1 | 184 | 186 | PF00082 | 0.682 |
CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.609 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.492 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.478 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.623 |
CLV_PCSK_PC1ET2_1 | 221 | 223 | PF00082 | 0.547 |
CLV_PCSK_PC1ET2_1 | 225 | 227 | PF00082 | 0.558 |
CLV_PCSK_PC1ET2_1 | 23 | 25 | PF00082 | 0.478 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.544 |
CLV_PCSK_SKI1_1 | 25 | 29 | PF00082 | 0.535 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.580 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.629 |
CLV_Separin_Metazoa | 8 | 12 | PF03568 | 0.545 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.528 |
DOC_CYCLIN_RxL_1 | 33 | 45 | PF00134 | 0.668 |
DOC_SPAK_OSR1_1 | 197 | 201 | PF12202 | 0.619 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.722 |
DOC_USP7_UBL2_3 | 19 | 23 | PF12436 | 0.492 |
DOC_USP7_UBL2_3 | 221 | 225 | PF12436 | 0.646 |
LIG_14-3-3_CanoR_1 | 226 | 235 | PF00244 | 0.463 |
LIG_14-3-3_CanoR_1 | 52 | 59 | PF00244 | 0.526 |
LIG_14-3-3_CanoR_1 | 72 | 76 | PF00244 | 0.582 |
LIG_14-3-3_CanoR_1 | 90 | 94 | PF00244 | 0.592 |
LIG_Actin_WH2_2 | 114 | 130 | PF00022 | 0.669 |
LIG_BIR_III_4 | 159 | 163 | PF00653 | 0.624 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.711 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.682 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.461 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.678 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.697 |
LIG_FHA_2 | 227 | 233 | PF00498 | 0.492 |
LIG_Integrin_RGD_1 | 185 | 187 | PF01839 | 0.799 |
LIG_Integrin_RGD_1 | 66 | 68 | PF01839 | 0.520 |
LIG_SH2_SRC | 77 | 80 | PF00017 | 0.656 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.605 |
LIG_SH3_2 | 207 | 212 | PF14604 | 0.630 |
LIG_SH3_3 | 161 | 167 | PF00018 | 0.672 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.547 |
LIG_SUMO_SIM_anti_2 | 6 | 11 | PF11976 | 0.556 |
LIG_TRAF2_1 | 216 | 219 | PF00917 | 0.597 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.610 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.511 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.657 |
MOD_CK1_1 | 89 | 95 | PF00069 | 0.608 |
MOD_CK2_1 | 144 | 150 | PF00069 | 0.637 |
MOD_CK2_1 | 213 | 219 | PF00069 | 0.668 |
MOD_CK2_1 | 226 | 232 | PF00069 | 0.492 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.647 |
MOD_GlcNHglycan | 46 | 50 | PF01048 | 0.641 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.687 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.715 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.625 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.618 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.714 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.529 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.682 |
MOD_PKA_1 | 226 | 232 | PF00069 | 0.608 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.529 |
MOD_PKA_2 | 62 | 68 | PF00069 | 0.579 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.609 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.627 |
MOD_PKB_1 | 224 | 232 | PF00069 | 0.449 |
MOD_Plk_1 | 77 | 83 | PF00069 | 0.699 |
MOD_Plk_2-3 | 145 | 151 | PF00069 | 0.652 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.563 |
MOD_SUMO_for_1 | 160 | 163 | PF00179 | 0.506 |
TRG_DiLeu_BaEn_1 | 122 | 127 | PF01217 | 0.540 |
TRG_ER_diArg_1 | 173 | 175 | PF00400 | 0.575 |
TRG_ER_diArg_1 | 182 | 185 | PF00400 | 0.536 |
TRG_ER_diArg_1 | 210 | 212 | PF00400 | 0.598 |
TRG_NLS_Bipartite_1 | 211 | 229 | PF00514 | 0.628 |
TRG_NLS_MonoCore_2 | 223 | 228 | PF00514 | 0.513 |
TRG_NLS_MonoExtC_3 | 220 | 225 | PF00514 | 0.547 |
TRG_NLS_MonoExtN_4 | 221 | 228 | PF00514 | 0.468 |
TRG_Pf-PMV_PEXEL_1 | 211 | 215 | PF00026 | 0.623 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZZ3 | Leptomonas seymouri | 45% | 100% |
A0A3S7WYA2 | Leishmania donovani | 72% | 100% |
A4I0P0 | Leishmania infantum | 72% | 100% |
D0A718 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AWP0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 100% |
Q4QAT1 | Leishmania major | 71% | 98% |
V5C0P2 | Trypanosoma cruzi | 35% | 100% |